The in vivo expressed Mycobacterium tuberculosis (IVE-TB) antigen Rv2034 induces CD4(+) T-cells that protect against pulmonary infection in HLA-DR transgenic mice and guinea pigs

Author(s):
Commandeur, S.; Eeden, S.J.F. van den; Dijkman, K.; Clark, S.O.; Meijgaarden, K.E. van (0000-0003-2818-9805); Wilson, L.; Franken, K.L.M.C.; Williams, A.; Christensen, D.; Ottenhoff, T.H.M. (0000-0003-3706-3403); Geluk, A. (0000-0001-8555-2872)
Published
2014
Publication type
Article / Letter to editor
HLA-DR3Infection-specificIVE-TB antigenMtbRv2034TB vaccine
Date issued
2014-06-17
Language
English
Is part of
Vaccine (2014), Vol. 32, no. 29, p. 3580-3588
hdl
1887/104570
doi
10.1016/j.vaccine.2014.05.005